The expression of ADAM33 gene in airway remodeling in a murine model of chronic asthma

JIE Zhi-jun,JIN Mei-ling,CAI Ying-yun,YUAN Zheng-hong,HU Yun-wen,XU Yang
DOI: https://doi.org/10.3969/j.issn.1006-5725.2009.06.010
2009-01-01
Abstract:Objective To investigate the expression of ADAM33 (a disintegrin and metalloproteinase 33) mRNA in airway remodeling in a murine model of chronic asthma. Methods Twenty female C57BL / 6 mice were randomly divided into two groups,10 for each group. Group A (chronic asthma model) received intraperitoneal injections of allergy-causing solution on days 1 and 14,and then 30 min inhalation of 2.5% OVA thrice weekly for 8 weeks from day 21; group B (saline control) received normal saline for sensibilization. 24 h after the final OVA challenge,bronchoalveolar lavage fluid (BALF) was collected for WBC total and differential counts. The mRNA expressions of ADAM33,inteleukin-4 (IL-4),and inteleukin-13 (IL-13) in the lungs were detected by real-time RT-PCR. The tissue sections from the left lung were stained with H&E and Masson's Trichrome staining,and were used for immunohistochemical staining for α-smooth muscle actin (α-SMA). Results in group A,the count and percentage of eosinophils in BALF [(6.3 ± 1.3) × 105/ mL and (18.1 ± 3.0)%] and the mRNA expressions of ADAM33,IL-4,and IL-13[(1.41 ± 0.93) × 10-2,(5.72 ± 3.89) × 10-2,and (9.45 ± 5.91) × 10-2] were markedly elevated,as compared with group B (P < 0.01); Masson's Trichrome staining showed an increased subepithelial collagen deposition and immunohistochemistry revealed evident airway smooth muscle thickening. Conclusions The expression of ADAM33 is increased in the murine model of chronic asthma induced by repeated low-dose OVA challenge,which may be involved in the genesis and development of airway remodeling.
What problem does this paper attempt to address?